About Seqker
Seqker is a Healthcare company founded in 2021. Advances personalized cancer therapies through genomic profiling and vaccine development. It operates on a B2B and Service-based model. Seqker offers products and services including Neoantigen Cancer Vaccine, Genomic Profiling, Preclinical Target Discovery, and Intelligent Platform. Its focus areas include Biotechnology, Genomics, Cancer Immunotherapy and Diagnostics. Its legal entity is Seqker Biosciences, Inc.
Company details
Seqker Biosciences is a platform-driven company focused on advancing personalized cancer treatments and diagnostics. It uses modular technology to analyze patients genomics for accurate neoantigen predictions and drug target identification. The company offers services like neoantigen cancer vaccine treatments, comprehensive genomic profiling, and preclinical target discovery through collaborations. Based on the provided text, it operates in a network of hospitals and partners with academia for innovation.
- SectorsHealthcare
- Website seqker.com
- Legal Name Seqker Biosciences, Inc.
Products & Services of Seqker
Seqker offers a comprehensive portfolio of products and services, including Neoantigen Cancer Vaccine, Genomic Profiling, Preclinical Target Discovery, and Intelligent Platform.
Personalized vaccine based on tumor neoantigens for cancer treatment.
Analyzes tumor and normal samples for actionable drug targets.
Identifies novel neoantigens for cancer indications via analysis.
Modular tool for genomics examination and neoantigen prediction.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Seqker
Seqker was founded in 2021.
Seqker Biosciences is a platform-driven company focused on advancing personalized cancer treatments and diagnostics. It uses modular technology to analyze patients genomics for accurate neoantigen predictions and drug target identification. The company offers services like neoantigen cancer vaccine treatments, comprehensive genomic profiling, and preclinical target discovery through collaborations. Based on the provided text, it operates in a network of hospitals and partners with academia for innovation.
Seqker offers Neoantigen Cancer Vaccine, Genomic Profiling, Preclinical Target Discovery, and Intelligent Platform.
Seqker operates through Seqker Biosciences, Inc..